New labeling solution delivers advanced UV protection for vials and syringes while enabling full product visibility for safer, more efficient drug handling.
Jersey City, NJ –IL Group, a specialist in multifunctional labeling solutions for the pharmaceuticals and healthcare sectors, introduces its Light Protect Pack, an advanced labeling product designed to preserve the stability and integrity of light-sensitive medications from packaging to administration, while enabling product visibility.
To ensure the sustained efficacy of photosensitive drugs, IL Group’s Light Protect Pack blocks harmful light at wavelengths as low as 380 nanometers (violet), providing exceptional protection against photodegradation. The solution series also includes options using amber material effective as low as 500 nanometers, allowing manufacturers to tailor light shielding based on specific product requirements. Lastly, a 700-nanometer aluminum label option rounds out the full suite of solutions sure to meet any labeling requirement.
Unlike conventional light-protective solutions, Light Protect Pack can successfully shield light even for applications using clear glass vials or syringes (both glass and plastic), allowing visual inspection during the reconstitution process while still providing long-range light protection. This ensures the stability of light-sensitive pharmaceuticals from packaging to administration, enhancing both product safety and usability.
“This labeling solution solves a long-standing challenge in pharmaceutical packaging: balancing visibility with protection,” said Eiji Funabashi, President for Iwata Label USA Inc. “With Light Protect Pack, manufacturers and healthcare providers get the best of both worlds – reliable light shielding and visual clarity – ensuring drug integrity, safety, and usability.”
About IL Group
Based in Aichi, Japan IL Group is a total pharmaceutical packaging solution provider. The company provides precision, often customized labeling solutions for global pharmaceutical and healthcare companies. In addition to its advanced pharmaceutical labeling solutions, IL Group provides clinical trial services, contract packaging services, and a series of high-efficiency labeling machines. Its extensive portfolio includes ISO-compliant roll-on and shrink-tack labels featuring value-added benefits such as tamper evidence, protection against breakage, and light-shielding properties, as well as specialty constructions whose functions range from reliable adhesion in cryogenic applications to detachable elements for ease of medical recordkeeping.
IL Group’s US entity, Iwata Label USA, combines elevated Japanese quality standards with a keen sense of North American market needs. In Japan, IL Group holds the predominant share of Japan’s pharmaceutical labeling market. Through its three-pole network in the US, Europe, and Japan, as well as various global partnerships, IL Group is poised for further growth and innovation. For more information, visit http://www.group-il.com/en.